1. Loss of 3-O-sulfotransferase enzymes, Hs3st3a1 and Hs3st3b1, reduces kidney and glomerular size and disrupts glomerular architecture.
- Author
-
Patel VN, Ball JR, Choi SH, Lane ED, Wang Z, Aure MH, Villapudua CU, Zheng C, Bleck C, Mohammed H, Syed Z, Liu J, and Hoffman MP
- Subjects
- Animals, Mice, Heparitin Sulfate metabolism, Glomerular Basement Membrane metabolism, Glomerular Basement Membrane pathology, Glomerular Basement Membrane ultrastructure, Kidney metabolism, Kidney pathology, Mice, Knockout, Sulfotransferases genetics, Sulfotransferases metabolism, Sulfotransferases deficiency, Kidney Glomerulus metabolism, Kidney Glomerulus pathology, Podocytes metabolism, Podocytes pathology, Podocytes ultrastructure
- Abstract
Heparan sulfate (HS) is an important component of the kidney anionic filtration barrier, the glomerular basement membrane (GBM). HS chains attached to proteoglycan protein cores are modified by sulfotransferases in a highly ordered series of biosynthetic steps resulting in immense structural diversity due to negatively charged sulfate modifications. 3-O-sulfation is the least abundant modification generated by a family of seven isoforms but creates the most highly sulfated HS domains. We analyzed the kidney phenotypes in the Hs3st3a1, Hs3st3b1 and Hs3st6 -knockout (KO) mice, the isoforms enriched in kidney podocytes. Individual KO mice show no overt kidney phenotype, although Hs3st3b1 kidneys were smaller than wildtype (WT). Furthermore, Hs3st3a1
-/- ; Hs3st3b1-/- double knockout (DKO) kidneys were smaller but also had a reduction in glomerular size relative to wildtype (WT). Mass spectrometry analysis of kidney HS showed reduced 3-O-sulfation in Hs3st3a1-/- and Hs3st3b1-/- , but not in Hs3st6-/- kidneys. Glomerular HS showed reduced HS staining and reduced ligand-and-carbohydrate engagement (LACE) assay, a tool that detects changes in binding of growth factor receptor-ligand complexes to HS. Interestingly, DKO mice have increased levels of blood urea nitrogen, although no differences were detected in urinary levels of albumin, creatinine and nephrin. Finally, transmission electron microscopy showed irregular and thickened GBM and podocyte foot process effacement in the DKO compared to WT. Together, our data suggest that loss of 3-O-HS domains disrupts the kidney glomerular architecture without affecting the glomerular filtration barrier and overall kidney function., Competing Interests: Declaration of competing interest JL is a founder and chief scientific officer for Glycan Therapeutics Corp. Other authors declare no competing interest., (Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF